Mandate

Vinge has advised Ambea AB (publ) in connection with its refinancing

Vinge advised Ambea AB (publ), the leading care provider in Scandinavia, in connection with a refinancing in an aggregate amount of SEK 5,000,000,000.

On 31 October 2022 Ambea AB (publ) entered into an unsecured facility agreement with a bank syndicate comprised of three Nordic banks. The new facility agreement has an initial term of three years with a one year extension option and consist of a SEK 4,000,000,000 committed facility and an uncommitted accordion option of SEK 1,000,000,000.

The purpose of the facility agreement is to refinance certain outstanding loans under the previous SEK 4,500,000,000 facility agreement and to increase the Ambea group’s overall financial flexibility.

Vinges team consisted of partner Albert Wållgren together with Josefine Lanker and Sofia Haggren.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025